Sarah J. Nelson mainly focuses on Magnetic resonance imaging, Pathology, Nuclear medicine, In vivo and Central nervous system disease. In general Magnetic resonance imaging study, her work on Magnetic resonance spectroscopic imaging often relates to the realm of Phased array, thereby connecting several areas of interest. Her biological study spans a wide range of topics, including Multiple sclerosis and Choline.
Her Nuclear medicine research includes elements of Mr spectroscopic imaging, Astrocytoma, Glioma, In vivo magnetic resonance spectroscopy and Radiation therapy. Sarah J. Nelson combines subjects such as Lactate dehydrogenase, Biochemistry, Metabolism, Nuclear magnetic resonance and Pharmacology with her study of In vivo. Her Central nervous system disease research incorporates elements of Lesion, Postmortem studies, Anatomy, Tumor progression and Atrophy.
Her primary areas of study are Magnetic resonance imaging, Nuclear medicine, Nuclear magnetic resonance, Pathology and Glioma. Sarah J. Nelson has researched Magnetic resonance imaging in several fields, including Prostate cancer, In vivo and Medical imaging. She has included themes like White matter, Lesion, Effective diffusion coefficient, Voxel and Radiation therapy in her Nuclear medicine study.
Her Nuclear magnetic resonance study integrates concerns from other disciplines, such as Image resolution, Imaging phantom, Mr spectroscopic imaging and Metabolite. Her research investigates the connection between Pathology and topics such as Oncology that intersect with issues in Temozolomide. The Glioma study combines topics in areas such as Brain tumor, Choline, Hyperintensity and IDH1.
Glioma, Internal medicine, Magnetic resonance imaging, Pathology and Oncology are her primary areas of study. Her studies deal with areas such as Metabolite, Ex vivo, Fluid-attenuated inversion recovery and IDH1 as well as Glioma. In her study, White matter is strongly linked to Multiple sclerosis, which falls under the umbrella field of Internal medicine.
Her research in Magnetic resonance imaging intersects with topics in Nuclear medicine, Nuclear magnetic resonance and Medical imaging. Her Nuclear medicine research integrates issues from Lesion, Voxel and Perfusion. Her study in Pathology is interdisciplinary in nature, drawing from both Text mining, In vivo and Metabolism.
The scientist’s investigation covers issues in Glioma, Internal medicine, Oncology, Nuclear magnetic resonance and Magnetic resonance imaging. Her research integrates issues of Metabolite, Ex vivo, Isocitrate dehydrogenase and IDH1 in her study of Glioma. Her Oncology study incorporates themes from Phases of clinical research, Pathology, Clinical endpoint, Bevacizumab and Radiation therapy.
Her Nuclear magnetic resonance research is multidisciplinary, relying on both Healthy volunteers, Image resolution, Temporal resolution, Imaging phantom and Pulse. The study incorporates disciplines such as Brain tumor, Angiogenesis and Glioblastoma in addition to Magnetic resonance imaging. Her Nuclear medicine research includes themes of Magnetic resonance spectroscopic imaging, Brain cancer, Glutamine and Radiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson;Tali Mazor;Chibo Hong;Michael Barnes.
Science (2014)
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate
Sarah J. Nelson;John Kurhanewicz;Daniel B. Vigneron;Peder E. Z. Larson.
Science Translational Medicine (2013)
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
J Kurhanewicz;D B Vigneron;H Hricak;P Narayan.
Radiology (1996)
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.
J Scheidler;H Hricak;D B Vigneron;K K Yu.
Radiology (1999)
Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading
Mark J. Albers;Robert Bok;Albert P. Chen;Charles H. Cunningham.
Cancer Research (2008)
Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens
Chris Dowling;Andrew W. Bollen;Susan M. Noworolski;Michael W. McDermott.
American Journal of Neuroradiology (2001)
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Radhika Srinivasan;Napapon Sailasuta;Ralph Hurd;Sarah Nelson.
Brain (2005)
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.
John Kurhanewicz;Mark G. Swanson;Sarah J. Nelson;Daniel B. Vigneron.
Journal of Magnetic Resonance Imaging (2002)
Prostate Cancer: Prediction of Extracapsular Extension with Endorectal MR Imaging and Three-dimensional Proton MR Spectroscopic Imaging
Kyle K. Yu;Juergen Scheidler;Hedvig Hricak;Daniel B. Vigneron.
Radiology (1999)
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
Benjamin M. Ellingson;Martin Bendszus;Martin Bendszus;Jerrold Boxerman;Daniel Barboriak.
Neuro-oncology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
Stanford University
University of California, San Francisco
Rutgers, The State University of New Jersey
California Institute of Technology
National University of Singapore
Swiss Tropical and Public Health Institute
The University of Texas Health Science Center at San Antonio
Case Western Reserve University
University of Cambridge
University of Avignon
Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences
University of Algarve
Langley Research Center
Max Planck Society
Tel Aviv University
Centers for Disease Control and Prevention
University of Calgary
The University of Texas MD Anderson Cancer Center